List of Studies ( Metabolite:4-Pyridone)
| Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Analysis Type |
|---|---|---|---|---|---|---|---|
| ST004036 | AN006674 | Metabolome Changes of Megachile rotundata Across Pupal Stages Measured by Mass Spectrometry-Based Untargeted Metabolomics | Insect tissue | Megachile rotundata | University of Wyoming | GC-MS | |
| ST003868 | AN006357 | Commensal Human Gut Microbes Produce Unique Patterns of Neuro-active Compounds | Microbial culture | Bacteria | Neurological Disorder | Medical University of South Carolina | LC-MS |
| ST003848 | AN006323 | Occurrence of white flesh color and refreshing flavor following phytoene synthase 2A gene variation in loquat fruit | Fruit | Loquat | Fujian Academy of Agricultural Science | LC-MS | |
| ST003311 | AN005423 | Complementary Omics Analyses of The Brain Of A Kainic Acid Epilepsy Model Reveal Alterations In Purine And Energy Metabolism With Metabolic Implications for miRNA Cargos Within Milk-Exosomes | Brain | Mouse | Epilepsy | University of Nebraska-Lincoln | GC-MS |
| ST003032 | AN004969 | Effects of Preanalytical Sample Collection and Handling on Comprehensive Metabolite Measurements in Human Urine Biospecimens | Urine | Human | National Center for Advancing Translational Sciences | Other | |
| ST002917 | AN004787 | Transporter-mediated depletion of apoplastic proline directly contributes to plant pattern-triggered immunity against a bacterial pathogen | Leaf | Arabidopsis thaliana | Bacterial infection | Oregon State University | GC-MS |
| ST002405 | AN003919 | Stool global metabolite levels in peanut allergy (Part 2) | Feces | Human | Peanut allergy | Icahn School of Medicine at Mount Sinai | LC-MS |
| ST002132 | AN003487 | Optimization of Imputation Strategies for High-Resolution Gas Chromatography-Mass Spectrometry (HR GC-MS) Metabolomics Data | Blood | Baboon | Wake Forest School of Medicine | GC-MS | |
| ST002132 | AN003487 | Optimization of Imputation Strategies for High-Resolution Gas Chromatography-Mass Spectrometry (HR GC-MS) Metabolomics Data | Liver | Baboon | Wake Forest School of Medicine | GC-MS | |
| ST001937 | AN003150 | Comprehensive plasma metabolomics and lipidomics based management of benign and malignant solitary pulmonary nodules | Blood | Human | Cancer | China Pharmaceutical University | GC-MS/LC-MS |
| ST001432 | AN002394 | A Compromised Developmental Trajectory of the Infant Gut Microbiome and Metabolome in Atopic Eczema - (untargeted global metabolomics profiling) ) | Feces | Human | Eczema | National University of Singapore | GC-MS |
| ST001190 | AN001982 | Sepsis-related metabolic changes in ileum, jejunum, skeletal muscle, liver and lung | Ileum | Pig | Sepsis | Indiana University School of Medicine | GC-MS |
| ST001190 | AN001982 | Sepsis-related metabolic changes in ileum, jejunum, skeletal muscle, liver and lung | Jejunum | Pig | Sepsis | Indiana University School of Medicine | GC-MS |
| ST001190 | AN001982 | Sepsis-related metabolic changes in ileum, jejunum, skeletal muscle, liver and lung | Liver | Pig | Sepsis | Indiana University School of Medicine | GC-MS |
| ST001190 | AN001982 | Sepsis-related metabolic changes in ileum, jejunum, skeletal muscle, liver and lung | Lung | Pig | Sepsis | Indiana University School of Medicine | GC-MS |
| ST001190 | AN001982 | Sepsis-related metabolic changes in ileum, jejunum, skeletal muscle, liver and lung | Muscle | Pig | Sepsis | Indiana University School of Medicine | GC-MS |
| ST001062 | AN001736 | Arabidopsis Nit1 knockout metabolomics | Plant | Arabidopsis thaliana | University of California, Davis | LC-MS | |
| ST000978 | AN001602 | Metabolomics biomarkers and the risk of overall mortality and ESRD in CKD: results from the Progredir Cohort. | Blood | Human | Kidney disease | University of Sao Paulo | GC-MS |
| ST000925 | AN001518 | MuRF1-Related Metabolomic Changes in Stretched and Unloaded HL-1 Cells | Cardiomyocyte cells | Mouse | University of North Carolina at Chapel Hill | GC-MS | |
| ST000895 | AN001457 | Analysis of the effects of Tyrosine Kinase Inhibitors Sunitinib and Erlotinib on Serum Metabolism In Vivo using Non-Targeted Metabolomics Analysis | Blood | Mouse | Cancer | University of North Carolina at Chapel Hill | GC-MS |
| ST000893 | AN001455 | Analysis of the effects of Tyrosine Kinase Inhibitors Sunitinib and Erlotinib on Heart, Metabolism In Vivo | Muscle | Mouse | Cancer | University of North Carolina at Chapel Hill | GC-MS |
| ST000589 | AN000904 | Effects of dilution on analyte identification and quantification | Blood | Human | Duke University | GC-MS | |
| ST000586 | AN000901 | Evaluation of specific concentrations for use in experimental protocol | Blood | Human | Duke University | GC-MS | |
| ST000532 | AN000811 | CHEAR Plasma Reference Material Plasma GC-MS | Blood | Human | RTI International | GC-MS | |
| ST000422 | AN000667 | Type 1 Diabetes good glycemic control and controls samples | Blood | Human | Diabetes | Mayo Clinic | LC-MS |
| ST000422 | AN000669 | Type 1 Diabetes good glycemic control and controls samples | Blood | Human | Diabetes | Mayo Clinic | LC-MS |
| ST000421 | AN000663 | ms3076 T1D poor glycemic control and control samples | Blood | Human | Diabetes | Mayo Clinic | LC-MS |
| ST000420 | AN000662 | NIST SRM Smoker non-Smoker Urine Comparison | Urine | Human | RTI International | GC-MS | |
| ST000418 | AN000660 | The role of CFTR in the regulation of intrinsic defense mechanisms of exocrine secretions | Saliva | Human | Cystic fibrosis | University of North Carolina | GC-MS |
| ST000164 | AN000256 | Metabolomic analysis of normal and diabetic mouse bone marrow under PBS or metformin treatment | Bone marrow | Mouse | Diabetes | New York University | LC-MS |
| ST000164 | AN000257 | Metabolomic analysis of normal and diabetic mouse bone marrow under PBS or metformin treatment | Bone marrow | Mouse | Diabetes | New York University | LC-MS |
| ST000047 | AN000080 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (CSF) | Cerebrospinal fluid | Human | Alzheimers disease | Mayo Clinic | LC-MS |
| ST000047 | AN000081 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (CSF) | Cerebrospinal fluid | Human | Alzheimers disease | Mayo Clinic | LC-MS |
| ST000046 | AN000076 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (plasma) | Blood | Human | Alzheimers disease | Mayo Clinic | LC-MS |
| ST000046 | AN000077 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (plasma) | Blood | Human | Alzheimers disease | Mayo Clinic | LC-MS |
| ST000046 | AN000078 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (plasma) | Blood | Human | Alzheimers disease | Mayo Clinic | LC-MS |
| ST000046 | AN000079 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (plasma) | Blood | Human | Alzheimers disease | Mayo Clinic | LC-MS |
